Piramal Enterprises Ltd buy melinda
Start price
07.09.17
/
50%
?35.17
Target price
14.09.17
€37.70
Performance (%)
7.33%
End price
14.09.17
€37.74
Summary
This prediction ended on 14.09.17 with a price of €37.74. With a performance of 7.33%, the BUY prediction by melinda for Piramal Enterprises Ltd closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Piramal Enterprises Ltd | - | - | - | - |
| iShares Core DAX® | 4.094% | 3.543% | 17.404% | 20.326% |
| iShares Nasdaq 100 | 1.424% | 0.512% | 39.212% | 55.365% |
| iShares Nikkei 225® | -1.572% | -4.633% | 15.731% | 2.146% |
| iShares S&P 500 | 1.822% | 0.963% | 30.396% | 45.950% |
Comments by melinda for this prediction
In the thread Piramal Enterprises Ltd diskutieren
Pharma SecteurProduits
Piramal Pharma Solutions ernennt John Fowler als Chief Operating Officer
MUMBAI, 7. September 2017 / PRNewswire / - Piramal Pharma Solutions (PPS), ein Teil der Piramal Enterprises Limited, gab heute die Ernennung von John Fowler als Chief Operating Officer. PPS ist ein führendes Unternehmen in der Entwicklung und Herstellung von integrierten Verträgen, mit einem globalen Netzwerk von 12 Entwicklungen ...
Stopped prediction by melinda for Piramal Enterprises Ltd
Piramal Enterprises Ltd
Start price
Target price
Perf. (%)
?31.43
12.03.18
12.03.18
€35.10
19.03.18
19.03.18
4.01%
19.03.18
19.03.18
Piramal Enterprises Ltd
Start price
Target price
Perf. (%)
?37.97
14.09.17
14.09.17
€39.26
20.02.18
20.02.18
-9.28%
20.02.18
20.02.18
Piramal Enterprises Ltd
Start price
Target price
Perf. (%)
?2,921.0
14.09.17
14.09.17
€3,020.0
20.02.18
20.02.18
-9.28%
20.02.18
20.02.18